Dr. Benedikt Ivanova

Oncology pharmacist · Osaka University Hospital · Japan (JP) · Oncology

Tier 2STK-0047GoodOwner MSL RARachel Adeyemi

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: NSCLC
Scientific interests: Brain metastases
Engagement preference: In person
Advisory boards: 1
Publications: 23
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 2: 2 per year (assumption)

Last engaged: 11 Apr 2026 (157 days ago)
Next planned contact: 11 Oct 2026
Last 6 months vs target: 100%
1 of 1 expected engagements

Insights from this stakeholder (1)

INS-0079Duration of response
11 Apr 2026 · Diagnosis and screening
MediumClosed

Engagement history (1)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
11 Apr 2026	Scientific exchange	Phone	Rachel Adeyemi	Vantrexa	Duration of responseInfusion-reaction management	1	—	Reviewed	ENG-0105

Timeline

11 Apr 2026
Scientific exchange
Duration of response, Infusion-reaction management

Related stakeholders (9)

Osaka University Hospital

Dr. Javier Weber
Pathologist
Tier 3
Dr. Noor Dubois
Thoracic medical oncologist
Tier 3
Dr. Yuki Quinn
Thoracic medical oncologist
Tier 2
Dr. Tomoko Ueda
Pathologist
Tier 2
Dr. Ximena Rossi
Radiation oncologist
Tier 1
Dr. Chloé Dubois
Pathologist
Tier 3
Dr. Farah Jensen
Primary care physician
Tier 1
Dr. Ximena Bauer
General neurologist
Tier 3
Dr. Andrea Fischer
General neurologist
Tier 2